Five Mayo Clinic investigators were selected to receive 2017 Education and Biobusiness/Biotechnology Awards from Regenerative Medicine Minnesota.
Regenerative Medicine Minnesota is a joint venture between the University of Minnesota and Mayo Clinic, and funded by the Minnesota Legislature, with the goal of distributing millions of dollars to advance regenerative medicine in the state through research, education, healthcare, and business. The program, which was funded during the 2014 legislative session for ten years, is in its third year of operation.
Mayo Clinic awardees include:
Jilian L. Foxen - Education Program Award (Grades 3-12)
Advancing Regenerative Medicine Through Education Minnesota K-8 Educators
Saranya P. Wyles - Education Program Award (Post-Secondary)
Minnesota Medical Student Guide to Proficiency in Regenerative Medicine and Surgery
Dan Dragomir-Daescu, Ph.D. - Biobusiness/Biotechnology Award
Controllable and automated system for synthesizing GMP magnetic nanoparticles for regenerative medicine applications
Yasuhiro Ikeda, DVM, Ph.D. - Biobusiness/Biotechnology Award
Mayo CRM-original iPSC-derived islet product in a retrievable, encapsulation device
Saad J. Kenderian, M.D. - Biobusiness/Biotechnology Award
Development of a chimeric antigen receptor T cell therapy platform at the Mayo Clinic
About Regenerative Medicine
Regenerative medicine focuses on the body’s natural ability to repair, replace, and regenerate damaged or aging tissues, and to restore functionality. Physicians and scientists are using native and bioengineered cells, assistive devices, and engineering platforms to develop new treatments with the potential to fully heal the underlying causes of diseases, rather than only manage disease symptoms. For more information on regenerative medicine, visit the Mayo Clinic Center for Regenerative Medicine website.
awards, grants, Mayo Clinic research, regenerative medicine, Regenerative Medicine Minnesota, Regenerative Medicine Minnesota, stem cells, Uncategorized, University of Minnesota